2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine

⇄

MYC proto-oncogene, bHLH transcription factor ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29377550 The FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma. 2018 Apr 2
2 25956709 Direct and indirect targeting of MYC to treat acute myeloid leukemia. 2015 Jul 1